These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 33520356)

  • 1. Progress and assessment of lncRNA DGCR5 in malignant phenotype and immune infiltration of human cancers.
    Xue C; Chen C; Gu X; Li L
    Am J Cancer Res; 2021; 11(1):1-13. PubMed ID: 33520356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA DGCR5 promotes lung adenocarcinoma (LUAD) progression via inhibiting hsa-mir-22-3p.
    Dong HX; Wang R; Jin XY; Zeng J; Pan J
    J Cell Physiol; 2018 May; 233(5):4126-4136. PubMed ID: 29030962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of long noncoding RNA DGCR5 in cancers: Focus on molecular targets.
    Al-Hawary SIS; Rodrigues P; Bangali H; Hassan ZF; Elawady A
    Cell Biochem Funct; 2024 Mar; 42(2):e3949. PubMed ID: 38379219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA DGCR5 promotes non-small cell lung cancer progression via sponging miR-218-5p.
    Wang J; Shu HZ; Xu CY; Guo SG
    Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9947-9954. PubMed ID: 31799664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical Functions of lncRNA DGCR5 in Cancers of the Digestive System.
    Hu C; Xu W; Wang B; Chen J; Zhou Z; Zhou G; Yuan C
    Curr Pharm Des; 2021; 27(40):4147-4151. PubMed ID: 34387158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA DGCR5 represses the development of hepatocellular carcinoma by targeting the miR-346/KLF14 axis.
    Wang YG; Liu J; Shi M; Chen FX
    J Cell Physiol; 2018 Jan; 234(1):572-580. PubMed ID: 30216442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DGCR5 Promotes Gallbladder Cancer by Sponging MiR-3619-5p via MEK/ERK1/2 and JNK/p38 MAPK Pathways.
    Liu S; Chu B; Cai C; Wu X; Yao W; Wu Z; Yang Z; Li F; Liu Y; Dong P; Gong W
    J Cancer; 2020; 11(18):5466-5477. PubMed ID: 32742494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA DGCR5 regulates the non-small cell lung cancer cell growth, migration, and invasion through regulating miR-211-5p/EPHB6 axis.
    Kang M; Shi J; Li B; Luo M; Xu S; Liu X
    Biofactors; 2019 Sep; 45(5):788-794. PubMed ID: 31241800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of long noncoding RNA DGCR5 contributes to the proliferation, migration, and invasion of cervical cancer by activating Wnt signaling pathway.
    Liu Y; Chang Y; Lu S; Xiang YY
    J Cell Physiol; 2019 Jul; 234(7):11662-11669. PubMed ID: 30552671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long noncoding RNA DGCR5 suppresses gastric cancer progression by acting as a competing endogenous RNA of PTEN and BTG1.
    Xu Y; Zhang G; Zou C; Gong Z; Wang S; Liu J; Ma G; Liu X; Zhang W; Jiang P
    J Cell Physiol; 2019 Jul; 234(7):11999-12010. PubMed ID: 30515803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long noncoding RNA DGCR5 represses hepatocellular carcinoma progression by inactivating Wnt signaling pathway.
    Wang XL; Shi M; Xiang T; Bu YZ
    J Cell Biochem; 2019 Jan; 120(1):275-282. PubMed ID: 30230592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. lncRNA DGCR5 inhibits the proliferation of colorectal cancer cells by downregulating miR-21.
    Huang H; Yang X; Chen J; Fu J; Chen C; Wen J; Mo Q
    Oncol Lett; 2019 Sep; 18(3):3331-3336. PubMed ID: 31452812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. lncRNA DGCR5 acts as a tumor suppressor in papillary thyroid carcinoma via sequestering miR-2861.
    Chen F; Yin S; Zhu J; Liu P; Yang C; Feng Z; Deng Z
    Exp Ther Med; 2019 Jan; 17(1):895-900. PubMed ID: 30651878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DGCR5 promotes cancer stem cell-like properties of radioresistant laryngeal carcinoma cells by sponging miR-506 via Wnt pathway.
    Tang T; Shan G
    J Cell Physiol; 2019 Aug; 234(10):18423-18431. PubMed ID: 30980388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of lncRNA DGCR5 correlates with better prognosis and inhibits bladder cancer progression via transcriptionally facilitating P21 expression.
    Fang C; He W; Xu T; Dai J; Xu L; Sun F
    J Cell Physiol; 2019 May; 234(5):6254-6262. PubMed ID: 30238982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA DGCR5 incudes tumorigenesis of triple-negative breast cancer by affecting Wnt/β-catenin signaling pathway.
    Jiang D; Wang C; He J
    J BUON; 2020; 25(2):702-708. PubMed ID: 32521856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. lncRNA DGCR5 Up-Regulates TGF-β1, Increases Cancer Cell Stemness and Predicts Survival of Prostate Cancer Patients.
    Li B; Guo Z; Liang Q; Zhou H; Luo Y; He S; Lin Z
    Cancer Manag Res; 2019; 11():10657-10663. PubMed ID: 31920375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA DGCR5 Isoform-1 Silencing Suppresses the Malignant Phenotype of Clear Cell Renal Cell Carcinoma via miR-211-5p/Snail Signal Axis.
    Zhong GX; Luo D; Fan YJ; Wang J; Liu BQ; Xu ZH; Zhang X
    Front Cell Dev Biol; 2021; 9():700029. PubMed ID: 34322486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knockdown of DGCR5 enhances the radiosensitivity of human laryngeal carcinoma cells via inducing miR-195.
    Tang T; Shan G; Zeng F
    J Cell Physiol; 2019 Aug; 234(8):12918-12925. PubMed ID: 30549038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA DiGeorge syndrome critical region gene 5: A crucial regulator in malignant tumors.
    Xia H; Huang Z; Liu S; Zhao X; He R; Wang Z; Shi W; Chen W; Li Z; Yu L; Huang P; Kang P; Su Z; Xu Y; Yam JWP; Cui Y
    Biomed Pharmacother; 2021 Sep; 141():111889. PubMed ID: 34323697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.